Vivodyne
San Francisco
About Vivodyne
Vivodyne develops lifelike human organs for drug testing and research purposes. The company utilizes robotic systems and artificial intelligence to create realistic human tissues that simulate various organ functions. This innovative approach allows for efficient testing of pharmaceuticals, aiming to replace traditional animal testing methods. By producing over 100,000 human tissues in a short timeframe, Vivodyne enhances the predictive accuracy of drug responses in humans. The organization is committed to improving the preclinical drug testing process, providing valuable insights that can lead to more effective therapies. Through its advanced technology, Vivodyne contributes to the evolution of biomedical research and development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $80.0M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2025)
- Website: vivodyne.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Lifestyle
Social Profiles
Canonical: https://fsome.com/organization/vivodyne-94067 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.